GB1121636A - Improved wound healing compositions - Google Patents

Improved wound healing compositions

Info

Publication number
GB1121636A
GB1121636A GB8762/66A GB876266A GB1121636A GB 1121636 A GB1121636 A GB 1121636A GB 8762/66 A GB8762/66 A GB 8762/66A GB 876266 A GB876266 A GB 876266A GB 1121636 A GB1121636 A GB 1121636A
Authority
GB
United Kingdom
Prior art keywords
cartilage
heating
wound healing
powder
healing compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8762/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1121636A publication Critical patent/GB1121636A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GB8762/66A 1965-02-26 1966-02-28 Improved wound healing compositions Expired GB1121636A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US435693A US3400199A (en) 1965-02-26 1965-02-26 Wound-healing cartilage powder

Publications (1)

Publication Number Publication Date
GB1121636A true GB1121636A (en) 1968-07-31

Family

ID=23729424

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8762/66A Expired GB1121636A (en) 1965-02-26 1966-02-28 Improved wound healing compositions

Country Status (5)

Country Link
US (1) US3400199A (cs)
CH (1) CH479305A (cs)
DE (1) DE1617317B2 (cs)
FR (1) FR1590066A (cs)
GB (1) GB1121636A (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302058A4 (en) * 1985-09-12 1990-02-05 Lescarden Inc PROCESS FOR TREATING ANIMAL CARTILAGE AND PRODUCT OBTAINED.
WO1995021632A1 (de) * 1994-02-14 1995-08-17 Ludwig Baumgartner Verfahren zur inaktivierung thermolabiler viren in biologischem material unter beibehaltung der kollagenen eigenschaften

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476855A (en) * 1965-02-26 1969-11-04 Leslie L Balassa Sterilizing and enhancing activity of a finely divided cartilage powder
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3786888A (en) * 1972-05-22 1974-01-22 Lockheed Missiles Space Torque compensated walking beam
US4216204A (en) * 1978-05-08 1980-08-05 Robertson Harry J Medical protein hydrolysate, process of making the same and processes of utilizing the protein hydrolysate to aid in healing traumatized areas
US4094973A (en) * 1973-10-24 1978-06-13 Robertson Harry J Medical protein hydrolysate and process of using the same
US3966908A (en) * 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4058213A (en) * 1976-07-06 1977-11-15 Irwin Stone Low temperature vapor phase sterilization and storage of biologically active injectable materials
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
US4350682A (en) * 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4444752A (en) * 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4806523A (en) * 1985-08-06 1989-02-21 Collagen Corporation Method of treating inflammation
US5529982A (en) * 1985-08-06 1996-06-25 Celtrix Pharmaceuticals, Inc. Inducing granulocyte production or B cell production in peripheral blood by TGF-β
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
US6974796B1 (en) 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20070231402A1 (en) 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
CA2288269A1 (en) * 1997-02-20 1998-08-27 Industrial Research Limited Angiogenesis inhibitors and activators from shark cartilage
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
US7790678B1 (en) 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
US20090274660A1 (en) 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7488348B2 (en) 2003-05-16 2009-02-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
WO2005058207A1 (en) 2003-12-11 2005-06-30 Isto Technologies, Inc. Particulate cartilage system
US20050260181A1 (en) * 2004-03-05 2005-11-24 Immunopath Profile, Inc. Compositions and methods for tissue repair
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20060251612A1 (en) * 2005-05-09 2006-11-09 Dimiter Kotzev Bioresorbable cyanoacrylate adhesives
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
WO2007025290A2 (en) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants and methods for repair, replacement and treatment of joint disease
AU2006292224B2 (en) 2005-09-19 2013-08-01 Histogenics Corporation Cell-support matrix and a method for preparation thereof
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
EP2265220A1 (en) * 2008-03-05 2010-12-29 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
WO2010083051A2 (en) * 2009-01-15 2010-07-22 ProChon Biotech, Ltd. Cartilage particle tissue mixtures optionally combined with a cancellous construct
WO2012143324A1 (en) 2011-04-19 2012-10-26 Bioiberica, S.A. Cartilage product
ES2403804B1 (es) * 2011-09-21 2014-07-15 Bioib�Rica, S.A. Producto de cartílago.
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
CA2963595C (en) 2014-10-28 2023-07-11 Biovotec As Micronized eggshell membrane particles and the use thereof to promote the healing of wounds
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN107530119B (zh) 2015-02-19 2021-05-07 凯蒂森特生物医药公司 用于产生热量的医疗装置和使用它的治疗方法
KR102702872B1 (ko) 2015-06-24 2024-09-05 바이오보텍 에이에스 미립자 난각막을 포함하는 조직 공학 스캐폴드
GB201519923D0 (en) 2015-11-11 2015-12-23 Biovotec Dac And Biovotec As Dry biocompatible disintegrateable films for delivering particulate egg shell membrane to a wound
US12076271B2 (en) 2019-12-10 2024-09-03 Candesant Biomedical, Inc. Medical devices for generating heat and methods of treatment using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318774A (en) * 1961-03-15 1967-05-09 Squibb & Sons Inc Treatment of osseous and other tissue
FR1317584A (fr) * 1961-03-15 1963-02-08 Olin Mathieson Méthode de traitement des tissus osseux et autres tissus
NL275983A (cs) * 1961-03-15 1900-01-01

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302058A4 (en) * 1985-09-12 1990-02-05 Lescarden Inc PROCESS FOR TREATING ANIMAL CARTILAGE AND PRODUCT OBTAINED.
WO1995021632A1 (de) * 1994-02-14 1995-08-17 Ludwig Baumgartner Verfahren zur inaktivierung thermolabiler viren in biologischem material unter beibehaltung der kollagenen eigenschaften

Also Published As

Publication number Publication date
US3400199A (en) 1968-09-03
DE1617317B2 (de) 1978-04-20
DE1617317A1 (de) 1971-03-25
CH479305A (de) 1969-10-15
FR1590066A (cs) 1970-04-13
DE1617317C3 (cs) 1978-12-21

Similar Documents

Publication Publication Date Title
GB1121636A (en) Improved wound healing compositions
Follis JR Studies on the biological effect of high frequency radio waves (radar)
Coppedge et al. Cozymase as a part of the hepatic estrogeninactivating system
SE8500033L (sv) Pulverblandning med hog propylenglykolhalt och forfarande for dess framstellning
Hagen The distribution of ascorbic acid between the particulate and non-particulate components of adrenal and liver cells
AU2607871A (en) Improvements in or relating to method and apparatus for the rearing of fish in an artificial environment
Witten et al. Studies of thorium X applied to human skin. II. Comparative findings of the penetration and localization of thorium X when applied in alcoholic solution, in ointment and in lacquer vehicles
GB1070965A (en) Improvements in anode composition for "water-activated battery"
FR2004934A1 (fr) Procede de liaison des ferrures de pales d'helices d'avions,et en particulier de pales d'helicopteres
JPS5587713A (en) Weakly acidic nursery powder
GB673103A (en) A process for treating dextran for use in pharmaceutical and therapeutical preparations
Gillette et al. Some effects of desoxycorticosterone glycoside on chick fibroblasts in vitro
ES334541A1 (es) Procedimiento para la preparacion de una composicion cauterizadora de las heridas de plantas.
Orskov et al. Utilization of salts of volatile fatty acids by growing sheep. 2. Effect of stage of maturity and hormone implantation on the utilization of volatile fatty acid salts as sources of energy for growth and fattening
Wetterberg et al. Effect of lighting conditions on the porphyrin content and morphology of the Harderian gland and on uterine morphology in the golden hamster
CH509771A (de) Verfahren zur Herstellung von in kaltem Wasser dispergierbaren Präparaten fettlöslicher Vitamine zur Verwendung als Nahrungs- und Futtermittelzusätze
Nofouzi et al. Effects of low frequency electromagnetic fields on growth, total antioxidant activity and morphology of the intestine in rainbow trout (Oncorhynchus mykiss)
Baird Lark Sparrow Collected in Rhode Island
NIKIFOROVA Characteristics of tissue culture growth of the mammary glands of mice from a non-cancer line (D) after the addition of androsterone and 17-beta-estradiol to the culture medium
GB1205906A (en) Method of preparing injectable liver extracts
Raeside Progesterone a precursor of testicular androgens in sheep.
Bennett et al. Further Studies on Effects of a Small Intestinal Microsomal Fraction Upon Transplantable Tumors.
Dehamer et al. ORIGIN OF CELLS REPOPULATING THE SPLEENS OF IRRADIATED MICE GIVEN MARROW CELLS AND THYMOCYTES1
Riviere et al. Thyroxine-induced regression of tadpole lymph glands
GB843375A (en) Adhesives in powder form